Eugia Pharma Specialities Ltd

🚀 Exploring the Future of Pharma Manufacturing at CPHI & PMEC India 2024! On 26th-27th November 2024, at the India Expo Center (IEML), Greater Noida, Delhi NCR, we had an insightful session on Continuous Innovation & Agile Manufacturing for Next-Generation Therapeutics. Moderated by Dr. Mahesh Bhalgat, Group CEO & MD of Veeda Clinical Research Limited, this session featured a powerhouse panel of industry experts, including Atul Shastri, President of Operations at Eugia Pharma Specialities Ltd, a wholly owned subsidiary of AUROBINDO PHARMA LTD Atul shared his valuable insights during the discussion on “Redefining the Future of Pharma: Pharma Manufacturing Conclave.” The session focused on cutting-edge strategies to enhance agility and drive continuous improvement in pharma manufacturing — laying the foundation for the therapies of tomorrow. #CPHIIndia2024 #PharmaInnovation #AgileManufacturing Yugandhar Puvvala Vishal Arora

🚀 Ignite Your Career with Eugia Pharma! We are hiring for Quality Assurance professionals! 👉 Send your CV to: 1. SHWETABH SINGH at shwetabh.singh@eugiapharma.com 2. Anil Kumar Singh at hreugia2@eugiapharma.com Harika Namburi AUROBINDO PHARMA LTD

Innovation Meets Excellence: Eugia US Team Visits Our State-of-the-Art R&D Facility at Pashamylaram, Hyderabad Last week, we had the privilege of hosting the Eugia US LLC team at our cutting-edge R&D unit in Pashamylaram, Hyderabad. It was an inspiring experience to showcase the innovation, passion, and dedication that drive our efforts in developing world-class solutions in the healthcare space. Together, we are paving the way for a healthier future. #R&D #Innovation #HealthcareExcellence #GlobalCollaboration #EugiaLifeSciences Yugandhar Puvvala Dinesh Shenoy PhD Adarsh Jain Mark Fedele Toni Picone (Tronco) Katherine Bowman Zakaria Barjous MBA AUROBINDO PHARMA LTD

Eugia Pharma Specialities Limited – a wholly owned subsidiary of AUROBINDO PHARMA LTD – is steadfast in its mission to deliver high-quality generic sterile injectables, oncology, hormonal, and ophthalmic medicines. We are proud to have a strong presence in the USA, with expanding footprints across Europe and several emerging markets. Recently, Eugia marked another milestone by launching three oncology products in Australia, with many more products in the pipeline for approval over the next 12 months. Our Eugia Australia team actively participated in the Medicines Management 2024 Conference at the Adelaide Convention Center, hosted by Advanced Pharmacy Australia. This impactful event, held from November 14-16, brought together pharmacy professionals to discuss advancements and innovation in the industry. Yugandhar Puvvala Vijay Natarajan Abhishek Khadria Vyas Sandip #EugiaPharma #Pharmaceuticals #Oncology #Innovation #MedicinesManagement2024 #Australia

Wishing you a Diwali filled with love, light, peace and prosperity. Happy Diwali!

Lyfius Pharma proudly announces the inauguration of its state-of-the-art Pen-G manufacturing facility, at Kakinada, Andhra Pradesh. With an annual production capacity of 15,000 metric tonnes (MT), the facility was virtually inaugurated by Hon’ble Prime Minister Shri. Narendra Modi. This facility represents a strategic investment of ₹2,500 crores, under the Government of India’s PLI Scheme, and exemplifies how private sector participation can significantly contribute to national growth, drive innovation, and enhance healthcare security. Read more in the Times of India article: https://lnkd.in/gsmEf3yS Apitoria Pharma Private Limited Eugia Pharma Specialities Ltd

With state-of-the-art facilities and accreditations from regulatory bodies, Aurobindo Pharma is dedicated to delivering high-quality services and ensuring patient safety. As a leading generic pharmaceutical company, we operate across both formulations and API segments, with end-to-end operations supported by a robust, vertically integrated supply chain. This enables us to consistently provide unmatched quality and value to our customers while enhancing production capacities, strengthening market competitiveness, and expanding our portfolio globally. We are #CommittedToAHealthierLife! Apitoria Pharma Private Limited Eugia Pharma Specialities Ltd

We are thrilled to announce that Eugia Pharma Specialities Ltd a subsidiary of the Aurobindo Pharma, has been honoured with the Merit Award at the NIPM National HR Excellence Awards! This recognition took place during the prestigious 40th NIPM National Conference (NATCON 2024), held at the Dr. TMA Pai International Convention Centre in Mangaluru on September 27th & 28th, 2024! This award reflects the dedication and hard work of our incredible team, whose commitment to innovative HR practices has been instrumental in this achievement. It underscores our focus on HR excellence, particularly through our 'Rapid Skill Building Initiatives,' which align perfectly with our advanced injectable machinery and the ongoing need for reskilling in a dynamic environment. A heartfelt thank you to the jury for recognising our efforts, and a huge shoutout to our exceptional team for making this possible! #HRAward #NATCON2024 #NIPMNationalHRExcellenceAwards #EugiaPharma #AurobindoPharma Vinod Krishnan Sudeep P R K Sureshkumar Iyer Yugandhar Puvvala Ankita Anand Kiran Kumar Prabhakaran Udhay Kailash S A

May all your battles be won, and happiness surround you. Wishing you a joyous and blessed Vijayadashami! #happydussehra!

"Thrilled to announce that our injectable manufacturing plant has received its first product approval from the US-FDA for #Lidocaine" A big thank you to our dedicated team for their hard work and diligence. Together, we are driving innovation and delivering trusted solutions to patients worldwide. AUROBINDO PHARMA LTD Eugia US LLC Eugia Pharma Canada